Upadhya Pratap, Vadala Rohit, A Arpitha
Department of Pulmonary Medicine, Jawaharlal Institute of Post Graduate Medical Education, Puducherry.
Department of Pulmonary, Sleep and Critical Care Medicine Metro Centre for Respiratory Diseases, Metro Multispecialty Hospital, Noida.
Monaldi Arch Chest Dis. 2020 Sep 22;90(4). doi: 10.4081/monaldi.2020.1424.
Patients of chronic obstructive pulmonary disease (COPD) during COVID-19 pandemic have higher morbidity. Treatment of these patients require aerosolization procedures like nebulization and noninvasive modalities for ventilation like non-invasive ventilation (NIV) and high flow nasal cannula (HFNC). Role of these procedures in corona virus transmission when treating a case of acute exacerbation of chronic obstructive pulmonary disease should be further studied.
在新冠疫情期间，慢性阻塞性肺疾病（COPD）患者的发病率更高。治疗这些患者需要雾化吸入等雾化程序以及无创通气方式，如无创通气（NIV）和高流量鼻导管（HFNC）。在治疗慢性阻塞性肺疾病急性加重病例时，这些程序在冠状病毒传播中的作用应进一步研究。
